Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Genjiro Suzuki is active.

Publication


Featured researches published by Genjiro Suzuki.


Neuropathology and Applied Neurobiology | 2016

Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins

Yvonne S. Davidson; Andrew Robinson; Xiawei Liu; Dongyue Wu; Claire Troakes; Sara Rollinson; Masami Masuda-Suzukake; Genjiro Suzuki; Takashi Nonaka; Jing Shi; Jinzhou Tian; Hisham Hamdalla; John Ealing; Anna Richardson; Matthew Jones; Stuart Pickering-Brown; Julie S. Snowden; Masato Hasegawa; David Mann

A hexanucleotide expansion in C9orf72 is the major genetic cause of inherited behavioural variant Frontotemporal dementia (bvFTD) and motor neurone disease (MND), although the pathological mechanism(s) underlying disease remains uncertain.


Human Molecular Genetics | 2017

Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes

Yoshinori Tanaka; Genjiro Suzuki; Takashi Matsuwaki; Masato Hosokawa; Geidy Serrano; Thomas G. Beach; Keitaro Yamanouchi; Masato Hasegawa; Masugi Nishihara

Abstract Progranulin (PGRN) haploinsufficiency resulting from loss‐of‐function mutations in the PGRN gene causes frontotemporal lobar degeneration accompanied by TDP‐43 accumulation, and patients with homozygous mutations in the PGRN gene present with neuronal ceroid lipofuscinosis. Although it remains unknown why PGRN deficiency causes neurodegenerative diseases, there is increasing evidence that PGRN is implicated in lysosomal functions. Here, we show PGRN is a secretory lysosomal protein that regulates lysosomal function and biogenesis by controlling the acidification of lysosomes. PGRN gene expression and protein levels increased concomitantly with the increase of lysosomal biogenesis induced by lysosome alkalizers or serum starvation. Down‐regulation or insufficiency of PGRN led to the increased lysosomal gene expression and protein levels, while PGRN overexpression led to the decreased lysosomal gene expression and protein levels. In particular, the level of mature cathepsin D (CTSDmat) dramatically changed depending upon PGRN levels. The acidification of lysosomes was facilitated in cells transfected with PGRN. Then, this caused degradation of CTSDmat by cathepsin B. Secreted PGRN is incorporated into cells via sortilin or cation‐independent mannose 6‐phosphate receptor, and facilitated the acidification of lysosomes and degradation of CTSDmat. Moreover, the change of PGRN levels led to a cell‐type‐specific increase of insoluble TDP‐43. In the brain tissue of FTLD‐TDP patients with PGRN deficiency, CTSD and phosphorylated TDP‐43 accumulated in neurons. Our study provides new insights into the physiological function of PGRN and the role of PGRN insufficiency in the pathogenesis of neurodegenerative diseases.


Journal of Biological Chemistry | 2016

Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils

Shotaro Shimonaka; Takashi Nonaka; Genjiro Suzuki; Shin-ichi Hisanaga; Masato Hasegawa

TAR DNA-binding protein of 43 kDa (TDP-43) has been identified as the major component of ubiquitin-positive neuronal and glial inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Aggregation of TDP-43 to amyloid-like fibrils and spreading of the aggregates are suggested to account for the pathogenesis and progression of these diseases. To investigate the molecular mechanisms of TDP-43 aggregation, we attempted to identify the amino acid sequence required for the aggregation. By expressing a series of deletion mutants lacking 20 amino acid residues in the C-terminal region in SH-SY5Y cells, we established that residues 274–313 in the glycine-rich region are essential for aggregation. In vitro aggregation experiments using synthetic peptides of 40 amino acids from this sequence and adjacent regions showed that peptides 274–313 and 314–353 formed amyloid-like fibrils. Transduction of these fibrils induced seed-dependent aggregation of TDP-43 in cells expressing wild-type TDP-43 or TDP-43 lacking nuclear localization signal. These cells showed different phosphorylated C-terminal fragments of TDP-43 and different trypsin-resistant bands. These results suggest that residues 274–353 are responsible for the conversion of TDP-43 to amyloid-like fibrils and that templated aggregation of TDP-43 by seeding with different peptides induces various types of TDP-43 pathologies, i.e. the peptides appear to act like prion strains.


Human Molecular Genetics | 2016

Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation

Yoshinori Tanaka; Takashi Nonaka; Genjiro Suzuki; Fuyuki Kametani; Masato Hasegawa

Profilin 1 (PFN1) is an actin monomer-binding protein essential for regulating cytoskeletal dynamics in all cell types. Recently, mutations in the PFN1 gene have been identified as a cause of familial amyotrophic lateral sclerosis (ALS). The co-aggregation of PFN1 bearing mutations that cause ALS with TDP-43 (a key molecule in both sporadic and some familial forms of ALS), together with the classical TDP-43 pathology detected in post-mortem tissues of patients with autosomal dominant PFN1 mutation, imply that gain-of-toxic-function of PFN1 mutants is associated with the onset of ALS. However, it remains unknown how PFN1 mutants cause ALS. We found mutant PFN1 that causes ALS formed cytoplasmic aggregates positive for ubiquitin and p62, and these aggregates sequestered endogenous TDP-43. In cells harboring PFN1 aggregates, formation of aggresome-like structures was inhibited in the presence of proteasome inhibitor, and conversion of LC3-I to LC3-II was suppressed in the presence of lysosome inhibitor. Further, insoluble TDP-43 was increased in both cases. Co-expression of ALS-linked mutant PFN1 and TDP-43 increased insoluble and phosphorylated TDP-43 levels. The C-terminal region of TDP-43, essential for aggregation of TDP-43, was also indispensable for the interaction with PFN1. Interestingly, insoluble fractions prepared from cells expressing ALS-linked mutant PFN1 functioned as a seed to induce accumulation and phosphorylation of TDP-43, indicating that TDP-43 accumulated in the presence of the PFN1 mutants is converted to prion-like species. These findings provide new insight into the mechanisms of neurodegeneration in ALS, suggesting that gain-of-toxic-function PFN1 gene mutation leads to conformational change of TDP-43.


Journal of Biological Chemistry | 2016

The Effect of Fragmented Pathogenic α-Synuclein Seeds on Prion-like Propagation.

Airi Tarutani; Genjiro Suzuki; Aki Shimozawa; Takashi Nonaka; Haruhiko Akiyama; Shin-ichi Hisanaga; Masato Hasegawa

Aggregates of abnormal proteins are widely observed in neuronal and glial cells of patients with various neurodegenerative diseases, and it has been proposed that prion-like behavior of these proteins can account for not only the onset but also the progression of these diseases. However, it is not yet clear which abnormal protein structures function most efficiently as seeds for prion-like propagation. In this study, we aimed to identify the most pathogenic species of α-synuclein (α-syn), the main component of the Lewy bodies and Lewy neurites that are observed in α-synucleinopathies. We prepared various forms of α-syn protein and examined their seeding properties in vitro in cells and in mouse experimental models. We also characterized these α-syn species by means of electron microscopy and thioflavin fluorescence assays and found that fragmented β sheet-rich fibrous structures of α-syn with a length of 50 nm or less are the most efficient promoters of accumulation of phosphorylated α-syn, which is the hallmark of α-synucleinopathies. These results indicate that fragmented amyloid-like aggregates of short α-syn fibrils are the key pathogenic seeds that trigger prion-like conversion.


Journal of Biological Chemistry | 2016

Phosphorylation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Truncated Casein Kinase 1δ Triggers Mislocalization and Accumulation of TDP-43

Takashi Nonaka; Genjiro Suzuki; Yoshinori Tanaka; Fuyuki Kametani; Shinobu Hirai; Haruo Okado; Tomoyuki Miyashita; Minoru Saitoe; Haruhiko Akiyama; Hisao Masai; Masato Hasegawa

Intracellular aggregates of phosphorylated TDP-43 are a major component of ubiquitin-positive inclusions in the brains of patients with frontotemporal lobar degeneration and ALS and are considered a pathological hallmark. Here, to gain insight into the mechanism of intracellular TDP-43 accumulation, we examined the relationship between phosphorylation and aggregation of TDP-43. We found that expression of a hyperactive form of casein kinase 1 δ (CK1δ1-317, a C-terminally truncated form) promotes mislocalization and cytoplasmic accumulation of phosphorylated TDP-43 (ubiquitin- and p62-positive) in cultured neuroblastoma SH-SY5Y cells. Insoluble phosphorylated TDP-43 prepared from cells co-expressing TDP-43 and CK1δ1-317 functioned as seeds for TDP-43 aggregation in cultured cells, indicating that CK1δ1-317-induced aggregated TDP-43 has prion-like properties. A striking toxicity and alterations of TDP-43 were also observed in yeast expressing TDP-43 and CK1δ1-317. Therefore, abnormal activation of CK1δ causes phosphorylation of TDP-43, leading to the formation of cytoplasmic TDP-43 aggregates, which, in turn, may trigger neurodegeneration.


Journal of Biological Chemistry | 2017

Following the fate of endocytosed fibrils

Masato Hasegawa; Genjiro Suzuki

Cell-to-cell transmission of intracellular protein aggregates is considered a central event in many neurodegenerative diseases, but little is known about the underlying molecular mechanisms. A new study employs fluorescence quenching to examine the fate of α-synuclein, a key molecule in the pathology of Parkinsons disease and related disorders, in primary cultured neurons, finding that endocytosis and lysosomal processing of exogenous fibrils may explain the transmission of α-synuclein pathology.


Journal of Biological Chemistry | 2018

The effect of truncation on prion-like properties of α-synuclein

Makoto Terada; Genjiro Suzuki; Takashi Nonaka; Fuyuki Kametani; Akira Tamaoka; Masato Hasegawa


The Japanese Biochemical Society/The Molecular Biology Society of Japan | 2017

Effects on cells due to differences in structure of α-synuclein aggregates

Sei Imura; Genjiro Suzuki; Masato Hasegawa; Shin-ichi Hisanaga


The Molecular Biology Society of Japan | 2016

Effect on the proteasome activity by α–synuclein aggregates of different structure

Sei Imura; Genjiro Suzuki; Shin-ichi Hisanaga; Masato Hasegawa

Collaboration


Dive into the Genjiro Suzuki's collaboration.

Top Co-Authors

Avatar

Masato Hasegawa

Laboratory of Molecular Biology

View shared research outputs
Top Co-Authors

Avatar

Takashi Nonaka

Institute of Medical Science

View shared research outputs
Top Co-Authors

Avatar

Shin-ichi Hisanaga

Tokyo Metropolitan University

View shared research outputs
Top Co-Authors

Avatar

Fuyuki Kametani

Tokyo Metropolitan University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Haruhiko Akiyama

Institute of Medical Science

View shared research outputs
Top Co-Authors

Avatar

Sei Imura

Tokyo Metropolitan University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge